Metformin use and long-term risk of benign prostatic hyperplasia: a population-based cohort study
Objective To assess whether metformin use affects risk of benign prostatic hyperplasia (BPH) by comparing the risk of BPH in men with type 2 diabetes who initiated first-line treatment with either metformin or sulfonylurea monotherapy between 2000 or 2006 in Northern Denmark. In this period, sulfony...
Guardado en:
Autor principal: | Bianka Darvalics |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d4b591fc2296480c9bfd02e50274811a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Correlation of prostate volume with 'International Prostate Symptom Score' and 'Benign Prostatic Hyperplasia-Impact Index' in benign prostatic hyperplasia
por: D Gnyawali, et al.
Publicado: (2016) -
Increased risk of subsequent benign prostatic hyperplasia in non-Helicobacter pylori-infected peptic ulcer patients: a population-based cohort study
por: Chu-Wen Fang, et al.
Publicado: (2020) -
Safety and efficacy of silodosin for the treatment of benign prostatic hyperplasia
por: Yoshida M, et al.
Publicado: (2011) -
High regional variation in prostate surgery for benign prostatic hyperplasia in Switzerland.
por: Maria M Wertli, et al.
Publicado: (2021) -
Lower urinary tract symptoms-Benign prostatic hyperplasia may increase the risk of subsequent inguinal hernia in a Taiwanese population: A nationwide population-Based cohort study.
por: Yi-Hsuan Wu, et al.
Publicado: (2020)